On the basis of these results, we hypothesized that preexisting differences in AR cistrome and AR-regulated transcriptome in CRPC tumors play an important role in SPT-mediated tumor inhibition and predispose tumor cells to inhibition by SPT. The gene discussed is AR; the disease is neoplasm.